Robert Andrew Douglas - 11 Nov 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO ResMed Inc.
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol
RMD
Transactions as of
11 Nov 2021
Net transactions value
-$1,953,279
Form type
4
Filing time
15 Nov 2021, 19:44:02 UTC
Previous filing
18 Oct 2021
Next filing
18 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $245,199 -945 -4.3% $259.47 21,266 11 Nov 2021 Direct F1, F2
transaction RMD ResMed Common Stock Options Exercise $465,920 +8,000 +38% $58.24 29,266 15 Nov 2021 Direct F3
transaction RMD ResMed Common Stock Sale $2,174,000 -8,000 -27% $271.75 21,266 15 Nov 2021 Direct F3
holding RMD ResMed Common Stock 210,407 11 Nov 2021 Douglas Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -8,000 -7.8% $0.000000 94,098 15 Nov 2021 ResMed Common Stock 8,000 $58.24 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/19/2020.
F2 Includes 62.8289 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.
F3 The transaction was conducted under a Rule 10b5-1 plan.
F4 Represents date options first became exercisable. Options vest 1/3 per year.